MPLT·56565P103·US·equity·Healthcare - Biotechnology-Activist
MPLT (MAPLIGHT THERAPEUTICS INC) is held by 45 institutional investors as of Q1 2026. Largest holders: GOLDMAN SACHS GROUP INC ($40.6M), BlackRock, Inc. ($27.2M), GEODE CAPITAL MANAGEMENT, LLC ($9.8M). Net institutional sentiment: Bullish.
See how MPLT's score breaks down across 4 SEC sources
Showing 1-20 of 52
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer